GENOMICS | GENETICS | R&D | DIAGNOSTIC TESTS

As part of the financing line concluded with Winance, Genomic Vision announces the issuance of the first tranche of convertible notes with warrants (OCABSA) for €0.8 million

Updated 2 years ago
Valoe Has Agreed on 5,000,000€ Financial Arrangement with Winance.

Updated 3 years ago
Genomic Vision Announces New Financing Line with Winance, Subject to Prior Approval of the Company’s Shareholders

Updated 3 years ago
ISSUE OF THE FINAL CONVERTIBLE NOTES AND WARRANTS PURSUANT TO FINANCING ARRANGEMENT BETWEEN VALOE CORPORATION AND WINANCE DISCLOSED ON 22 APRIL 2020.

Updated 3 years ago
Genomic Vision announces the issuance of 2 new tranches of convertible notes with warrants for €2 million,

NEWS

GENOMICS | GENETICS | R&D | DIAGNOSTIC TESTS

Related News

Valoe Has Agreed on 5,000,000€ Financial Arrangement with Winance.

Genomic Vision Announces New Financing Line with Winance, Subject to Prior Approval of the Company’s Shareholders

ISSUE OF THE FINAL CONVERTIBLE NOTES AND WARRANTS PURSUANT TO FINANCING ARRANGEMENT BETWEEN VALOE CORPORATION AND WINANCE DISCLOSED ON 22 APRIL 2020.

Genomic Vision announces the issuance of 2 new tranches of convertible notes with warrants for €2 million,